Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) have been assigned a consensus rating of “Buy” from the ...

Scheduled for 13 weeks, the trial will assess the therapy’s safety, tolerability, and efficacy in weight loss.

The initiation of the phase 2 study is based on early-stage data, which show that patients who received VKTX's obesity pill ...

Some of the best possible returns for investors come by not going after megacaps, but instead pursuing stocks that have more ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...

Eli Lilly and Company’s LLY shares declined 13.5% in the past three months. Though demand for its popular tirzepatide drugs, ...

The Vikings added quarterback Daniel Jones to the active roster this week and questions about his role in Monday night’s game against the Rams came up during head coach Kevin O’Connell’s press ...

NASCAR asks federal judge to dismiss teams' antitrust lawsuit (January 8, 2025, 6:31 PM ET) Helio Castroneves to attempt to qualify for Daytona 500 (January 6, 2025, 5:49 PM ET) ...

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...